SCA – Corporate Governance Questionnaire

SCA – CG Report Checklist (AI)

1. A statement of the procedures taken to complete the corporate governance system during 2025 and how to implement them

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


2. A statement of the ownership and transactions of the members of the Board of Directors, their spouses, and children in the company's securities during 2025

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


3. Formation of the Board of Directors


A statement regarding the current formation of the Board of Directors (including the names of resigned and newly appointed Board members).

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the percentage of female representation on the Board of Directors for the year.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement explaining the reasons for not nominating any female candidates for membership on the Board of Directors.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Total remuneration paid to members of the Board of Directors for the year 2024.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Total proposed remuneration of the members of the Board of Directors for the year 2025, which will be presented at the annual general assembly meeting for approval.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement detailing the allowances received by board members attending committee meetings during the fiscal year 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Details of additional allowances, salaries, or fees received by Board members, apart from allowances for committee attendance and their reasons.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


The number of Board of Directors meetings held during the fiscal year 2025, including the dates of their holding and the number of personal attendances for all members, as well as those attending by proxy.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


The number of Board of Directors’ decisions made during the fiscal year 2025, along with a statement of the dates of the meetings.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


4. Board of Directors’ Committees


A declaration by the Chairman of the Audit Committee of his responsibility for the committee system within the company and for reviewing its operational mechanism and ensuring its effectiveness.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Names of the Audit Committee members, along with a statement of its competencies and assigned tasks.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Number of meetings held by the Audit Committee during 2025 and their dates to discuss matters related to the financial statements and any other matters, and a statement of the number of times members attended the meetings in person.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


4.1 Nominations and Remuneration Committee


A declaration by the Chairman of the Nominations and Remuneration Committee of his responsibility for the committee system within the company and for reviewing its operational mechanism and ensuring its effectiveness.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Names of the Nominations and Remuneration Committee members, along with their respective competencies and assigned tasks.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the number of meetings held by the committee during 2025 and the dates of these meetings, along with a statement of the number of times all members attended in person.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


4.2 Committee for Monitoring and Supervising the Transactions of Stakeholders


A declaration by the Chairman of the Committee or an authorized representative regarding his responsibility for the committee system within the company and for reviewing its operational mechanism and ensuring its effectiveness.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Names of the members of the committee for monitoring and supervising the transactions of stakeholders, along with a statement of its competencies and assigned tasks.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Summary of the committee’s work report for the year 2025. (If the committee was not formed, a clarification of the reasons should be provided).

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


4.3 Other Committees Approved by the Board of Directors


Name of the committee(s).

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Names of the members of each committee, along with a statement of its competencies and assigned tasks.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the number of meetings held by the committee during the year 2025 and the dates of their convening, along with a statement of the number of times all committee members attended in person.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


5. Delegation of Tasks and Competencies of the Board of Directors


A statement of the tasks and competencies of the Board of Directors carried out by a member of the Board or the Executive Management during the year 2025 based on a delegation from the Board, specifying the duration and validity of the delegation according to the table.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


6. Transactions Made with Related Parties


A statement detailing the transactions made with related parties (stakeholders) during the year 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


7. Organizational Structure and Executive Management


The complete organizational structure of the company, showing the Managing Director and/or General Manager and/or CEO, Deputy General Manager and managers working in the company such as the Financial Manager.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


The complete organizational structure of the company, showing the Managing Director and/or General Manager and/or CEO, Deputy General Manager and managers working in the company such as the Financial Manager.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


The complete organizational structure of the company, showing the Managing Director and/or General Manager and/or CEO, Deputy General Manager and managers working in the company such as the Financial Manager.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


8. External Auditor


Providing a brief overview of the company’s auditor to shareholders.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement detailing the fees and costs associated with the audit or services provided by the external auditor, according to the table.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement clarifying the reservations included by the company’s auditor in the interim and annual financial statements for the year 2025. In the absence of any reservations, this should be explicitly stated

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


9. Internal Control System


A declaration by the Board of Directors of its responsibility for the internal control system within the company and for reviewing its operational mechanism and ensuring its effectiveness.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Name of the department manager, his qualifications and date of appointment.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Name of the compliance officer, his qualifications and date of appointment.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


How the Internal Control Department handles any major problems in the company or those disclosed in the annual reports and accounts (In the absence of major problems, this should be clearly stated).

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Number of reports issued by the Internal Control Department to the Board of Directors of the company.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


10. Details of violations committed during 2025, including their causes, how to address them, and how to avoid their recurrence in the future.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


11. A statement of the cash and in-kind contributions made by the company during 2025 towards local community development and environmental preservation. (If no contributions were made, this should be stated clearly).

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


12. General Information


A statement of the company’s share price in the market (closing price, highest price, and lowest price) at the end of each month during the fiscal year 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the comparative performance of the company' share with the general market index and the sector index to which the company belongs during the year 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A breakdown of shareholder ownership as of 31/12/2025 categorized as individuals, companies, and governments and further classified into local, Gulf, Arab, and foreign.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of shareholders owning 5% or more of the company's capital as of 31/12/2025 according to the table.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of how shareholders are distributed according to the volume of ownership as of 31/12/2025 according to the table.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement detailing the procedures taken regarding investor relations controls, stating the following: The name of the investor relations officer. Contact information for investor relations (email, phone, mobile, fax). An electronic link to the investor relations webpage on the company's website.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Statement of special resolutions presented at the General Assembly held during 2025 and the actions taken in this regard.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Name of the rapporteur of the Board of Directors’ meetings and date of appointment.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A detailed statement of the material events and important disclosures that the company encountered during 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the transactions that the company concluded with related parties during 2025, which equal 5% or more of the company’s capital.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the percentage of Emiratization within the company at the end of the years 2023, 2024, 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


A statement of the innovative projects and initiatives that the company has undertaken or are being developed during 2025.

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Has the Chairman of the Board of Directors signed?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Has the Chairman of the Audit Committee signed?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Has the Chairman of the Nominations and Remuneration Committee signed?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Has the Director of the Internal Control Department signed?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Was the report prepared on the company’s official letterhead and bear the company’s official seal?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Was the report disclosed at least 10 days before the General Assembly meeting and before the end of March 2025?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Was the report made available in both Arabic and English?

Please select “Disclosed” or “Not disclosed”, provide clear notes, and upload supporting evidence. Incomplete information may lead to the disclosure being rejected.


Scroll to Top